← Eichor
Study identifier: NCT06194682 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Anterior Cruciate Ligament Study

Condition: ACL Injury · ACL · Anterior Cruciate Ligament Rupture  ·  Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

PhaseN/A
Planned participants370
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This retrospective, prospective observational study aims to evaluate the epidemiology and rate of anterior cruciate ligament re- rupture after surgery in patients treated from January 2020 to December 2030 by recording both clinically and radiographically ligament reconstruction. The primary outcome is the rate of rupture of the anterior cruciate ligament as measured by the Lachmann test in which a positive value for re-rupture is an anterior translation of the tibia greater than 10mm relative to the femur Secondary Objectives: Verify predisposing factors to anterior cruciate ligament injuries (so anatomical factors such as tibial slope, trochlear groove), demographic factors (age, sex, weight, sports played), and the rate of return to sports, quality of life via questionnaires, and arthrosis at the operated knee

This description comes directly from the study's public registry record.

Talk to the study team

Riccard D'Ambrosi, MD  ·  +393397066151  ·  riccardo.dambrosi@hotmail.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS Istituto Ortopedico GaleazziMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06194682